Table 3.
20-yr survivors n = 155 | 20-yr non-survivors n = 140 | P | |
eGFR > 60 | 126 (80%) | 112 (79%) | 0.860 |
MIRF | 31 (20%) | 29 (21%) | 0.879 |
SIRF | 7 (4.5%) | 4 (2.9%) | 0.453 |
eGFR 30-39 | 10 (6.5%) | 5 (3.6%) | 0.261 |
eGFR 40-49 | 8 (5.2%) | 7 (5.0%) | 0.950 |
eGFR 50-59 | 8 (5.2%) | 13 (9.3%) | 0.169 |
eGFR 60-69 | 10 (6.5%) | 28 (20%) | 0.001 |
eGFR 70-79 | 10 (6.5%) | 22 (15.7%) | 0.011 |
eGFR 80-89 | 22 (14.2%) | 13 (9.3%) | 0.193 |
eGFR 90-99 | 16 (10.3%) | 14 (10.0%) | 0.927 |
eGFR 100-109 | 15 (9.7%) | 9 (6.4%) | 0.308 |
eGFR 110-119 | 10 (6.5%) | 7 (5.0%) | 0.593 |
eGFR > 120 | 47 (30.3%) | 28 (20.0%) | 0.042 |
LT: Liver transplantation; eGFR: Estimated glomerular filtration rate; MIRF: Moderately impaired renal function; SIRF: Severely impaired renal function.